N-[3-[4-[2-[3-(aminomethyl)anilino]pyrimidin-4-yl]-5-methyl-1H-pyrazol-3-yl]phenyl]-2-fluorobenzamide
C28H24FN7O — CID 143251258
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-[4-[2-[3-(aminomethyl)anilino]pyrimidin-4-yl]-5-methyl-1H-pyrazol-3-yl]phenyl]-2-fluorobenzamide
N-[3-[4-[2-[3-(aminomethyl)anilino]pyrimidin-4-yl]-5-methyl-1H-pyrazol-3-yl]phenyl]-2-fluorobenzamide (PubChem CID 143251258) has the molecular formula C28H24FN7O and a molecular weight of 493.55 g/mol. Its IUPAC name is N-[3-[4-[2-[3-(aminomethyl)anilino]pyrimidin-4-yl]-5-methyl-1H-pyrazol-3-yl]phenyl]-2-fluorobenzamide.
Molecular Properties
| Compound Name | N-[3-[4-[2-[3-(aminomethyl)anilino]pyrimidin-4-yl]-5-methyl-1H-pyrazol-3-yl]phenyl]-2-fluorobenzamide |
|---|---|
| PubChem CID | 143251258 |
| Molecular Formula | C28H24FN7O |
| Molecular Weight | 493.55 g/mol |
| Exact Mass | 493.20 |
| IUPAC Name | N-[3-[4-[2-[3-(aminomethyl)anilino]pyrimidin-4-yl]-5-methyl-1H-pyrazol-3-yl]phenyl]-2-fluorobenzamide |
| SMILES | Cc1[nH]nc(-c2cccc(NC(=O)c3ccccc3F)c2)c1-c1ccnc(Nc2cccc(CN)c2)n1 |
| InChI | InChI=1S/C28H24FN7O/c1-17-25(24-12-13-31-28(34-24)33-20-8-4-6-18(14-20)16-30)26(36-35-17)19-7-5-9-21(15-19)32-27(37)22-10-2-3-11-23(22)29/h2-15H,16,30H2,1H3,(H,32,37)(H,35,36)(H,31,33,34) |
| InChIKey | RNBZMKWFMPWDNV-UHFFFAOYSA-N |
| XLogP | 5.44 |
| TPSA | 121.61 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 493.55 |
| LogP ≤ 5 | 5.44 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143251258 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.